Anthrax Toxin Inhibitor

Newly Identified Inhibitor of Anthrax Toxin May Contribute to Safer Vaccine and Offer Postexposure Therapy. ‘A newly identified inhibitor of the anthrax toxin may be used to develop a safer and more effective vaccine and act as a therapeutic agent after exposure say researchers from Massachusetts and Germany. Their findings appear in the June 2005 issue of the journal Infection and Immunity.’

Anthrax Toxin Meets Nano Inhibitor. ‘Researchers from Rensselaer Polytechnic and the University of Toronto have designed a nanoscale liposome-based inhibitor of anthrax toxin. The nanodevice technology created by the investigators is thought to have potential applications to other disease toxins, and one day could be used for such common and devastating conditions as sepsis, HIV and influenza infections.’

Centers for Disease Control and Prevention: Anthrax Anthrax Investigation

Speak Your Mind